Navigation Links
Merz Pharmaceuticals Commends The Benign Essential Blepharospasm Research Foundation On 30 Years Of Community Support
Date:7/22/2011

GREENSBORO, N.C., July 22, 2011 /PRNewswire/ -- Merz Pharmaceuticals, LLC, commends the Benign Essential Blepharospasm Research Foundation (BEBRF) for 30 years of dedication to increasing awareness of blepharospasm, a neurological disorder that causes abnormal, involuntary spasms of the muscles around the eye, and raising funds for research. Founded on July 23, 1981, BEBRF has grown to be an invaluable resource for the blepharospasm community.

Many people living with blepharospasm have spent months or even years experiencing the symptoms of uncontrollable eyelid blinking before receiving an accurate diagnosis. It was a similar delay in diagnosis and an overall lack of awareness among both physicians and the public that motivated Mattie Lou Koster to form BEBRF 30 years ago. Today, her daughter Mary Lou Thompson continues to lead the organization, which aims to undertake, promote, develop and carry on the search for the cause and a cure for blepharospasm.

"I'm so pleased to celebrate how far BEBRF has come in the past 30 years," said Mary Lou, President of BEBRF. "It's been such an honor for me to continue my mother's goal of creating a foundation that addresses the needs of patients while raising awareness of blepharospasm so it becomes more easily recognized. I thank the remarkable members of the blepharospasm community and our supportive partners for all of their hard work over the years."

Through a network of local support groups, educational activities and collaboration with other organizations that have similar goals, BEBRF has had a significant impact on the blepharospasm community. The symposiums, newsletters, website, pamphlets and other materials provided by the organization have been influential in helping people better understand their diagnosis while raising awareness of the condition.

"BEBRF has bettered the lives of blepharospasm sufferers and their families worldwide in the last 30 years," said Richard L. Anderson, M.D., F.A.C.S., Center for Facial Appearances, Salt Lake City, Utah. "I look forward to seeing the advances made by BEBRF in the next three decades and I am very proud to be on the Board of this foundation."

In an effort to continue bringing resources to people with blepharospasm across the U.S., Merz Pharmaceuticals will expand its support of BEBRF beyond the national level by providing assistance to local BEBRF support groups.  For more information about how Merz can assist your local blepharospasm support group, please contact Merz Professional Services at 1-800-334-0514.

"When I was first diagnosed with blepharospasm nearly 25 years ago, I didn't know where to go for more information," said Anita Croce, BEBRF North Central District Director. "My doctor referred me to BEBRF and since then, I've been working closely with the Foundation to ensure others living with this condition know they're not alone. I'm proud to have seen BEBRF mature from the beginning years to where we are today, with undaunted dedication to empowering patients and providing opportunities to share experiences, encouragement, hope and knowledge."

Although there is no cure for blepharospasm at this time, there are treatments available, including botulinum toxin injections, drug therapy and surgery.

"On this occasion of the 30th anniversary of BEBRF, I wish the foundation continued success in its pursuit of the primary mission to improve the quality of life of each and every person living with blepharospasm through support of research, education and services," said Joseph Jankovic, M.D., Director of the Parkinson's Disease Center and Movement Disorders Clinic at Baylor College of Medicine, Houston, Texas. "For me, being a founding member and the first Chairman of the Medical Advisory Board of the BEBRF, and having the privilege to know Mattie Lou and Mary Lou, have been among the most rewarding experiences in my personal and professional life, for which I will always be grateful."

For more information about BEBRF, including local support group meetings, visit www.blepharospasm.org.

About Blepharospasm    

Blepharospasm is a rare neurological disorder that affects the muscles around the eye that are used to blink. It can result in involuntary contractions in the eyelids which can vary from an increased blink rate and intermittent eyelid spasm to eyelid closing for most of the day. Blepharospasm usually begins in the fifth to sixth decade of life and is more common in women than in men.

According to an epidemiology study conducted in Rochester, Minn. focal dystonia (which includes cervical dystonia and blepharospasm) is estimated to affect 295 per million people in the U.S.

About Merz

Merz Pharmaceuticals, LLC is a part of the Merz Group of companies and was established in 1995 to develop and commercialize products for the Merz Group. Areas of therapeutic focus include Neurology, Physiatry, Dermatology, and Podiatry.

With over a century of heritage, the Merz Group is known worldwide for its development of original compounds and formulations for medical professionals and consumers in 90 countries. Globally, Merz is a leader in the development of pharmaceuticals for the treatment of neurological and psychological disorders as well as for aesthetic medicine. Global research is concentrated in fields that have a strong need for therapeutic innovation such as Alzheimer's disease, Parkinson's disease, tinnitus, chronic pain conditions, addictions, and neuromuscular disturbances.


'/>"/>
SOURCE Merz Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
2. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
3. ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7)
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada
6. Access Pharmaceuticals MuGard Included in TRICARE Prescription Drug Coverage
7. Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011
8. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
9. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
10. Cumberland Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
11. Access Pharmaceuticals MuGard Added to CVS Caremarks Pharmacy Benefit Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016 /PRNewswire/ ... a foot-focused suite of products designed to support ... ExoSOLS™, are custom orthotic insoles that combine years ... 1,000 partners in the podiatric field with cutting ... align, and propel . It is supported by ...
(Date:2/11/2016)... , February 11, 2016 ... Market Report 2016 research report provides information on ... development status with crucial statistical data and information ... http://www.deepresearchreports.com/142870.html . --> Complete report on ... companies and supported with 296 tables and figures ...
(Date:2/10/2016)... 2016   Genomic Health, Inc. (Nasdaq: GHDX ) ... year ended December 31, 2015. --> ... 2015, compared with $69.1 million in the fourth quarter of 2014, ... increased 9 percent compared with the same period in the prior ... was $63.9 million in the fourth quarter of 2015, an increase ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... 11, 2016 , ... Life is known for throwing curves. It’s thrown quite ... gather once a year to play softball to raise money through Sun Health ... than 50 players who competed in this year’s softball tournament share a history of ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... and updated its hallmark resource, Infusion Therapy Standards of Practice, to include vascular ... vein illumination with an estimated 85% share of the market, facilitates adherence to ...
(Date:2/11/2016)... ... 11, 2016 , ... Dickinson Insurance & Financial Services continues their commitment to ... support of a local boy named Barrett, who has been fighting ALL leukemia for ... rally support for, all local families dealing with childhood cancer. Information on how to ...
(Date:2/11/2016)... ... 11, 2016 , ... Be Well Medical Group (Be Well) is ... Town at 108 South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group ... in the convenience of their homes, offices or at the practices’ local office. It ...
(Date:2/11/2016)... ... ... Husted Kicking has completed its Third Annual Husted Kicking College ... 2016 according to kicking coach Michael Husted. , “This event serves as an official ... Indianapolis,” says Husted. “The NFL uses a third party organization to select players for ...
Breaking Medicine News(10 mins):